APA

Potter R. A., Griffin D. A., Sondergaard P. C., Johnson R. W., Pozsgai E. R., Heller K. N., Peterson E. L., Lehtimäki K. K., Windish H. P., Mittal P. J., Albrecht D. E., Mendell J. R. & Rodino-Klapac L. R. (20190624). Systemic Delivery of Dysferlin Overlap Vectors Provides Long-Term Gene Expression and Functional Improvement for Dysferlinopathy. : Human gene therapy.

Chicago

Potter Rachael A, Griffin Danielle A, Sondergaard Patricia C, Johnson Ryan W, Pozsgai Eric R, Heller Kristin N, Peterson Ellyn L, Lehtimäki Kimmo K, Windish Hillarie P, Mittal Plavi J, Albrecht Douglas E, Mendell Jerry R and Rodino-Klapac Louise R. 20190624. Systemic Delivery of Dysferlin Overlap Vectors Provides Long-Term Gene Expression and Functional Improvement for Dysferlinopathy. : Human gene therapy.

Harvard

Potter R. A., Griffin D. A., Sondergaard P. C., Johnson R. W., Pozsgai E. R., Heller K. N., Peterson E. L., Lehtimäki K. K., Windish H. P., Mittal P. J., Albrecht D. E., Mendell J. R. and Rodino-Klapac L. R. (20190624). Systemic Delivery of Dysferlin Overlap Vectors Provides Long-Term Gene Expression and Functional Improvement for Dysferlinopathy. : Human gene therapy.

MLA

Potter Rachael A, Griffin Danielle A, Sondergaard Patricia C, Johnson Ryan W, Pozsgai Eric R, Heller Kristin N, Peterson Ellyn L, Lehtimäki Kimmo K, Windish Hillarie P, Mittal Plavi J, Albrecht Douglas E, Mendell Jerry R and Rodino-Klapac Louise R. Systemic Delivery of Dysferlin Overlap Vectors Provides Long-Term Gene Expression and Functional Improvement for Dysferlinopathy. : Human gene therapy. 20190624.